We describe a protocol for the precise integration of exogenous DNA into user-defined genomic loci in cultured cells. This strategy first introduces a promoter and a lox site to a specific location via a Cas9-induced double-strand break. Second, a gene of interest (GOI) is inserted into the lox site via Cre-lox recombination. Upon correct insertion, a cis-linked antibiotic resistance gene will be expressed from a promoter introduced into the genome in the first step assuring selection for correct integrants. Last, the selection cassette is excised via a Flp-FRT recombination event, leaving a precisely targeted GOI. This method is broadly applicable to any exogenous DNA to be integrated, choice of integration site, and choice of cell type. The most remarkable aspect of this versatile approach, termed “CasPi” (cascaded precise integration), is that it allows for precise genome targeting with large, frequently complex, and repetitive DNA sequences that do not integrate efficiently or at all with current genome targeting methods.
Get full access to this article
View all access options for this article.
References
1.
CapecchiMR. Altering the genome by homologous recombination. Science, 1989; 244:1288–1292. DOI: 10.1126/science.2660260.
2.
SmithiesO, GreggRG, BoggsSS, et al.Insertion of DNA sequences into the human chromosomal beta-globin locus by homologous recombination. Nature, 1985; 317:230–234. DOI: 10.1038/317230a0.
3.
HastyP, BradleyA. Gene targeting vectors for mammalian cells. In JoynerAL (ed). Gene Targeting: A Practical Approach. Oxford: Oxford University Press, 1993, 1–31.
4.
UrnovFD, RebarEJ, HolmesMC, et al.Genome editing with engineered zinc finger nucleases. Nat Rev Genet, 2010; 11:636–646. DOI: 10.1038/nrg2842.
5.
JoungJK, SanderJD. TALENs: a widely applicable technology for targeted genome editing. Nat Rev Mol Cell Biol, 2013; 14:49–55. DOI: 10.1038/nrm3486.
6.
CongL, RanFA, CoxD, et al.Multiplex genome engineering using CRISPR/Cas systems. Science, 2013; 339:819–823. DOI: 10.1126/science.1231143.
7.
JinekM, ChylinskiK, FonfaraI, et al.A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science, 2012; 337:816–821. DOI: 10.1126/science.1225829.
8.
AdliM. The CRISPR tool kit for genome editing and beyond. Nat Commun, 2018; 9:1911. DOI: 10.1038/s41467-018-04252-2.
9.
Pickar-OliverA, GersbachCA. The next generation of CRISPR-Cas technologies and applications. Nat Rev Mol Cell Biol, 2019; 20:490–507. DOI: 10.1038/s41580-019-0131-5.
10.
SakumaT, NakadeS, SakaneY, et al.MMEJ-assisted gene knock-in using TALENs and CRISPR-Cas9 with the PITCh systems. Nat Protoc, 2016; 11:118–133. DOI: 10.1038/nprot.2015.140.
11.
NakadeS, TsubotaT, SakaneY, et al.Microhomology-mediated end-joining-dependent integration of donor DNA in cells and animals using TALENs and CRISPR/Cas9. Nat Commun, 2014; 5:5560. DOI: 10.1038/ncomms6560.
12.
SuzukiK, TsunekawaY, Hernandez-BenitezR, et al.In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration. Nature, 2016; 540:144–149. DOI: 10.1038/nature20565.
13.
KuhnR, TorresRM. Cre/loxP recombination system and gene targeting. Methods Mol Biol, 2002; 180:175–204. DOI: 10.1385/1-59259-178-7:175.
14.
YarmolinskyM, HoessR. The legacy of Nat Sternberg: the genesis of Cre-lox technology. Annu Rev Virol, 2015; 2:25–40. DOI: 10.1146/annurev-virology-100114-054930.
15.
SchweizerHP. Applications of the Saccharomyces cerevisiae Flp-FRT system in bacterial genetics. J Mol Microbiol Biotechnol, 2003; 5:67–77. DOI: 10.1159/000069976.
16.
TuranS, ZeheC, KuehleJ, et al.Recombinase-mediated cassette exchange (RMCE)—a rapidly-expanding toolbox for targeted genomic modifications. Gene, 2013; 515:1–27. DOI: 10.1016/j.gene.2012.11.016.
17.
AlbertH, DaleEC, LeeE, et al.Site-specific integration of DNA into wild-type and mutant lox sites placed in the plant genome. Plant J, 1995; 7:649–659. DOI: 10.1046/j.1365-313x.1995.7040649.x.
18.
OberdoerfferP, OtipobyKL, MaruyamaM, et al.Unidirectional Cre-mediated genetic inversion in mice using the mutant loxP pair lox66/lox71. Nucleic Acids Res, 2003; 31:e140. DOI: 10.1093/nar/gng140.
19.
FukushigeS, SauerB. Genomic targeting with a positive-selection lox integration vector allows highly reproducible gene expression in mammalian cells. Proc Natl Acad Sci U S A, 1992; 89:7905–7909. DOI: 10.1073/pnas.89.17.7905.
20.
CoxMM. The FLP protein of the yeast 2-microns plasmid: expression of a eukaryotic genetic recombination system in Escherichia coli. Proc Natl Acad Sci U S A, 1983; 80:4223–4227. DOI: 10.1073/pnas.80.14.4223.
21.
JiX, WangY, LiJ, et al.Application of FLP-FRT system to construct unmarked deletion in Helicobacter pylori and functional study of gene hp0788 in pathogenesis. Front Microbiol, 2017; 8:2357. DOI: 10.3389/fmicb.2017.02357.
MatsudaT, CepkoCL. Controlled expression of transgenes introduced by in vivo electroporation. Proc Natl Acad Sci U S A, 2007; 104:1027–1032. DOI: 10.1073/pnas.0610155104.
24.
KirchmaierS, LustK, WittbrodtJ. Golden GATEway cloning—a combinatorial approach to generate fusion and recombination constructs. PLoS One, 2013; 8:e76117. DOI: 10.1371/journal.pone.0076117.
25.
ZhangF, CongL, LodatoS, et al.Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription. Nat Biotechnol, 2011; 29:149–153. DOI: 10.1038/nbt.1775.
26.
HockemeyerD, SoldnerF, BeardC, et al.Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat Biotechnol, 2009; 27:851–857. DOI: 10.1038/nbt.1562.
27.
NakamaeK, NishimuraY, TakenagaM, et al.Establishment of expanded and streamlined pipeline of PITCh knock-in—a web-based design tool for MMEJ-mediated gene knock-in, PITCh designer, and the variations of PITCh, PITCh-TG and PITCh-KIKO. Bioengineered, 2017; 8:302–308. DOI: 10.1080/21655979.2017.1313645.
28.
LiY, PolakU, BhallaAD, et al.Excision of expanded GAA repeats alleviates the molecular phenotype of Friedreich's ataxia. Mol Ther, 2015; 23:1055–1065. DOI: 10.1038/mt.2015.41.
29.
SoragniE, HermanD, DentSY, et al.Long intronic GAA*TTC repeats induce epigenetic changes and reporter gene silencing in a molecular model of Friedreich ataxia. Nucleic Acids Res, 2008; 36:6056–6065. DOI: 10.1093/nar/gkn604.
30.
BaeS, KweonJ, KimHS, et al.Microhomology-based choice of Cas9 nuclease target sites. Nat Methods, 2014; 11:705–706. DOI: 10.1038/nmeth.3015.
31.
BeeL, FabrisS, CherubiniR, et al.The efficiency of homologous recombination and non-homologous end joining systems in repairing double-strand breaks during cell cycle progression. PLoS One, 2013; 8:e69061. DOI: 10.1371/journal.pone.0069061.
32.
MaoZ, BozzellaM, SeluanovA, et al.Comparison of nonhomologous end joining and homologous recombination in human cells. DNA Repair (Amst), 2008; 7:1765–1771. DOI: 10.1016/j.dnarep.2008.06.018.
33.
ChenY, CaoJ, XiongM, et al.Engineering human stem cell lines with inducible gene knockout using CRISPR/Cas9. Cell Stem Cell, 2015; 17:233–244. DOI: 10.1016/j.stem.2015.06.001.
34.
LombardoA, CesanaD, GenoveseP, et al.Site-specific integration and tailoring of cassette design for sustainable gene transfer. Nat Methods, 2011; 8:861–869. DOI: 10.1038/nmeth.1674.
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
